1[1]Tamminga CA,Buchanan RW,Gold JM.The role of negative symptoms and cognitive dysfunction in schizophrenia outcome.Int Clin Psychopharmacol,1998,13:s21
2[2]Collins AA,Remigton GJ,Coulter K,et al.Insight,neurocognitive function and symptom clusters in chronic schizophrenia.Schizophrenia Research,1997,27:37
3[3]Davidson M,Harvey P,Welsh KA,et al.Cognitive functioning in late-life schizophrenia:a comparison of elderly schizophrenic patients and patients with Alzheimer's disease.Am J Psychiatry,1996,153:1274
4[4]Mizuno M,Kato M,Sartori G,et al.Performance characteristics of chronic schizophrenia on attention tests sensitive to unilateral brain damage.J Ner & Mental Disease,1997,185:427
5[5]Perlick D,Mattis S,Stastny P,et al.Neuropsychological discriminators of Long-term inpatient or outpatient status in chronic schizophrenia.J Neuropsychiatry Clin Neurosci,1992,4:428
6[6]Royall DR,Mahurin RK,True JE,et al.Executive impairment among the functionally dependent:comparisons between schizophrenic and elderly subjects.Am J Psychiatry,1993,150:1813
7[7]Goldberg SC,Gold JM.Neurocognitive functioning in patients with schizophrenia:an overview,In:Psychopharmacology:a fourth generation of progress.Bloom F,Kupter D(editors).New York,Raven Press,1245～1257
8Goldberg TE,Torrey EF, Gold JM,et al. Risk of neuropsychd - ogical impairment in monozygotic twius dideontant and concordant for schizophrenia. Schimphrenia, 1995,17 ( 1 ) :77 -84.
9Friedman JI, Temporini H, Davis HL. Pharmacologic strate gies for augmenting cognitive performance in schizophrenia. Biol Psychiatry, 1999,45( 1 ) :1.
10Serective- Schreiber D, Bruno Rm,Carter CS,et al. Dopamine and mechanisms of cognition: Part I. A nerval network model predicting dopamine effects on selective attention. Biol Psychiatry, 1998,43 (5) :713.
